/ Media Room
For Journalists, Analysts, and Storytellers
Downloadable logo pack
Company boilerplate and mission statement
Corporate Deck
Timeline graphic (Science to HOPE)
Podcast BiohackerBlondie
Empowered Patient Podcast
We are pleased to share a recent interview featuring Ronald Lane of HOPE-Neuron Therapeutx on the Empowered Patient Podcast with Karen Jagoda.
In this discussion, Dr. Lane outlines HOPE-Neuron’s Immune Modulation Therapy approach for Amyotrophic Lateral Sclerosis (ALS), focusing on the scientific rationale for targeting neuroinflammation and the broader therapeutic implications for patients facing this devastating disease.
The conversation highlights the role of immune dysregulation in ALS progression and the importance of advancing evidence-based strategies designed to meaningfully impact outcomes.
This dialogue comes at an important moment. Public awareness of ALS continues to grow — including recent visibility through Eric Dane’s advocacy — reinforcing the need for sustained research, clinical innovation, and informed discussion around next-generation therapeutic approaches.
At HOPE-Neuron, our commitment remains clear: advancing science-driven solutions with the goal of delivering measurable impact for patients and families affected by ALS.
Start ListeningIn this discussion, Dr. Lane outlines HOPE-Neuron’s Immune Modulation Therapy approach for Amyotrophic Lateral Sclerosis (ALS), focusing on the scientific rationale for targeting neuroinflammation and the broader therapeutic implications for patients facing this devastating disease.
The conversation highlights the role of immune dysregulation in ALS progression and the importance of advancing evidence-based strategies designed to meaningfully impact outcomes.
This dialogue comes at an important moment. Public awareness of ALS continues to grow — including recent visibility through Eric Dane’s advocacy — reinforcing the need for sustained research, clinical innovation, and informed discussion around next-generation therapeutic approaches.
At HOPE-Neuron, our commitment remains clear: advancing science-driven solutions with the goal of delivering measurable impact for patients and families affected by ALS.
